Why Pharmaceutical Water is Kept In Circulation 24/7

SAJJAD AHMAD

7M+ Impressions | 42K Connections | Pharmacist | Founder Of Pharmainform | Production Manager |

Published Jul 19, 2024

Water has great importance in pharmaceutical industries as it is used for all washing activities & is also used for various manufacturing processes.

It is a common observation that pharmaceutical water is distributed through a closed-loop system & this water remains in continuous circulation 24 hours a day & 7 days a week.

The circulation of pharma-grade water is not stopped even when the shift is closed or there is a manufacturing plant holiday.

Did you ever think about what is the reason behind this 24/7 continuous circulation of water in pharma?

Click to Read complete article

Pharmainform

16,950 followers

+ Subscribe

Misbah Bashir

4mo

Very helpful!

1 Reaction

Mercy Mindo

Quality Assurance

5mo

Thanks for sharing

1 Reaction

Prabhakar Patil

DGM Quality compliance and Operation at Alkem Laboratories Ltd.

5mo

Thanks for sharing

1 Reaction

Javed Hussain

DGM HR and Admin at Confidential

5mo

Great tips

1 Reaction

Mahmood Hayat Khan

Head of legal team of Sitara Chemicals

5mo

Useful tips

1 Reaction

See more comments

To view or add a comment, sign in

Why Pharmaceutical Water is Kept In Circulation 24/7

SAJJAD AHMAD

7M+ Impressions | 42K Connections | Pharmacist | Founder Of Pharmainform | Production Manager |

Pharmainform

16,950 followers

More articles by SAJJAD AHMAD

Insights from the community

Others also viewed

Pharma supply chain process flow & Key Stages from Research to Patient Delivery"

ECHA’s BPC supports the approval of nitrogen generated from ambient air as a low-risk active substance

How to define Lot and Batch in pharmaceutical industry

PNEUMATIC CONVEYING OF PHARMACEUTICAL POWDERS

Exciting collaboration between Unibloc® Hygienic Technologies and a leading global pharmaceutical company.

FDA Publishes Final Guidance on Classification of Co-Crystals

USP Class VI Materials

Cambrex invests $24 Million in new Highly Potent API manufacturing capacity at its Charles City, Iowa facility.

What is the impact of recent changes in FDA guidance on regulatory and intellectual property issues?

Containment of highly potent APIs in a pharmaceutical manufacturing environment has not always been compatible with efficiency.

Explore topics

Pharmainform

16,950 followers

More articles by SAJJAD AHMAD

How to calculate Assay or Potency of API

7 steps to become a skilled pharmacist

Tablet compression machine tooling

Learn All About Cleanrooms | Classification & ISO Standards

7 Wrong Practices In Pharma

Learn all about Hold Time Studies For Drug Products

Why tablet manufacturing area has negative pressure

How To Calculate Formable & Printed Foil For Blister Machine

Tablet Manufacturing FAQs

Why 70% IPA Is More Effective | 70% Vs 100% Disinfectant

Insights from the community

Others also viewed

Pharma supply chain process flow & Key Stages from Research to Patient Delivery"

ECHA’s BPC supports the approval of nitrogen generated from ambient air as a low-risk active substance

How to define Lot and Batch in pharmaceutical industry

PNEUMATIC CONVEYING OF PHARMACEUTICAL POWDERS

Exciting collaboration between Unibloc® Hygienic Technologies and a leading global pharmaceutical company.

FDA Publishes Final Guidance on Classification of Co-Crystals

USP Class VI Materials

Cambrex invests $24 Million in new Highly Potent API manufacturing capacity at its Charles City, Iowa facility.

What is the impact of recent changes in FDA guidance on regulatory and intellectual property issues?

Containment of highly potent APIs in a pharmaceutical manufacturing environment has not always been compatible with efficiency.

Explore topics